Commentary on "Enteral Lactoferrin Supplementation for Prevention of Sepsis and Necrotizing Enterocolitis in Preterm Infants".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Prebiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.The Cochrane database of systematic reviews · 2023
   Pooled it
2. Synbiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.The Cochrane database of systematic reviews · 2022
   Pooled it
3. Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.The Cochrane database of systematic reviews · 2022
   Pooled it
4. A Review of Probiotic Interventions for Necrotizing Enterocolitis and Sepsis in Preterm Infants.International journal of molecular sciences · 2026
   Review

Corrections and comments

• Comment on
  Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.2020

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as